Skip to content

McKesson MCK Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

Cardinal Health logo
Cardinal HealthCAH
$160M-84.8%
Cencora logo
CencoraCOR
$187.36M+12.2%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$558K-67.6%
AbbVie logo
AbbVieABBV
Medline, Inc.
 logo
Medline, Inc. MDLN
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.8%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$88.46B+2.1%
Enterprise value$86.77B-8.5%
P/E18.6×-8.8×
P/S0.2×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp
FCF margin1.4%-0.1pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The official record: McKesson’s 10-K, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is McKesson's noncontrolling interests in subsidiaries?
McKesson (MCK) reported noncontrolling interests in subsidiaries of $395M in Q1 2026.
How has McKesson's noncontrolling interests in subsidiaries changed year-over-year?
McKesson's noncontrolling interests in subsidiaries increased by 3.9% year-over-year, from $380M to $395M.
What is the long-term trend for McKesson's noncontrolling interests in subsidiaries?
Over 5 years (2021 to 2026), McKesson's noncontrolling interests in subsidiaries has grown at a 15.0% compound annual growth rate (CAGR), from $196M to $395M.
What does noncontrolling interests in subsidiaries mean?
This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.